Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.

Aier Eye Hospital Group Co., Ltd.

中山大学眼科中心 provides medical services specializing in ophthalmology, including treatment for various eye diseases and educational programs in the field. The center is described as the largest public ophthalmology hospital in China.

中山大学眼科中心

爱尔眼科 is a global ophthalmic medical group with over 800 ophthalmic medical institutions and over 7000 ophthalmologists and optometrists.  The self-described leading provider offers a wide range of ophthalmic services and specializes in 14 sub-specialty areas, including refractive surgery, optometry, cataracts, and ophthalmic imaging.  It also features various specialized clinics.

Metric
Company Name	Aier Eye Hospital Group Co., Ltd.	中山大学眼科中心
Symbol	300.01K
MSH ID	COM:AIERCHINA	COM:GZZOC
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Care Facilities	Healthcare
Country	CN	CN
Stage
Employee Count	36.72K
Website	aierchina.com	gzzoc.com
LinkedIn
Founders

Metric
Market Cap	13.82B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	2.80B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.42B
EBITDA	916.96M
Operating Income	680.57M
Net Income	462.00M
EPS	0.05
Diluted EPS	0.05
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.51
Operating Profit Margin	0.24
EBITDA Margin	0.33
Net Profit Margin	0.18
Return on Equity	0.19
Return on Assets	0.12
Return on Capital Employed	0.20

3000

COM:AIERCHINA

爱尔眼科

Last Close

14.28

25/11 07:04

Market Cap

100.45B

Beta: -

Volume Today

98.53M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	28.49
P/B Ratio	5.02
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	8.54
EV Multiple	30.24

Metric
Days Sales Outstanding	44.15
Days Payables Outstanding	87.27
Days Inventory Outstanding	35.19
Operating Cycle	77.10
Cash Conversion Cycle	4.44
Asset Turnover	0.66

Metric
Operating Cash Flow	807.65M
Free Cash Flow	606.88M
Cash Flow to Debt	2.09
Operating Cash Flow/Sales	0.27
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	838.90M
Accounts Receivable
Inventory	123.75M
Goodwill	898.56M
Debt to Capitalization	0.22
Debt to Assets	0.15
Current Ratio	1.70
Quick Ratio	1.71

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.02
SG&A to Revenue	0.04